JPS6289624A - 播種性血管内凝固症候群予防・治療剤 - Google Patents

播種性血管内凝固症候群予防・治療剤

Info

Publication number
JPS6289624A
JPS6289624A JP60230523A JP23052385A JPS6289624A JP S6289624 A JPS6289624 A JP S6289624A JP 60230523 A JP60230523 A JP 60230523A JP 23052385 A JP23052385 A JP 23052385A JP S6289624 A JPS6289624 A JP S6289624A
Authority
JP
Japan
Prior art keywords
dic
preventing
picibanil
coagulation
disseminated intravascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60230523A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6323175B2 (show.php
Inventor
Jiro Tsubouchi
坪内　二郎
Mutsumi Kazama
風間　睦美
Hidemi Ishii
秀美 石井
Denichi Mizuno
水野　伝一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Original Assignee
Research Development Corp of Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Corp of Japan filed Critical Research Development Corp of Japan
Priority to JP60230523A priority Critical patent/JPS6289624A/ja
Publication of JPS6289624A publication Critical patent/JPS6289624A/ja
Publication of JPS6323175B2 publication Critical patent/JPS6323175B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP60230523A 1985-10-16 1985-10-16 播種性血管内凝固症候群予防・治療剤 Granted JPS6289624A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60230523A JPS6289624A (ja) 1985-10-16 1985-10-16 播種性血管内凝固症候群予防・治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60230523A JPS6289624A (ja) 1985-10-16 1985-10-16 播種性血管内凝固症候群予防・治療剤

Publications (2)

Publication Number Publication Date
JPS6289624A true JPS6289624A (ja) 1987-04-24
JPS6323175B2 JPS6323175B2 (show.php) 1988-05-16

Family

ID=16909077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60230523A Granted JPS6289624A (ja) 1985-10-16 1985-10-16 播種性血管内凝固症候群予防・治療剤

Country Status (1)

Country Link
JP (1) JPS6289624A (show.php)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017186302A (ja) * 2016-02-03 2017-10-12 世叡 王 抗凝固に用いる医薬組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017186302A (ja) * 2016-02-03 2017-10-12 世叡 王 抗凝固に用いる医薬組成物

Also Published As

Publication number Publication date
JPS6323175B2 (show.php) 1988-05-16

Similar Documents

Publication Publication Date Title
Bonadonna et al. Clinical evaluation of adriamycin, a new antitumour antibiotic
Alfaham et al. The idiopathic hypereosinophilic syndrome.
CA2468314C (en) The use of water-soluble lamarin in the treatment of cancer
JPH04504710A (ja) 抗血栓組成物
CH661871A5 (it) Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta.
JP2001519471A (ja) アンジェリカ・ギガス・ナカイから精製した新規のペクチン質多糖類とその精製方法およびその免疫刺激剤としての使用
Kalayoglu-Besisik et al. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years
CA2066155A1 (en) Antiviral agent for human immunodeficiency virus
FR2568774A2 (fr) Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique
JPH02108624A (ja) 抗ｈｉｖ作用を有するヘパリンフラグメント及びフラクション
JPH05271088A (ja) 皮膚疾患・免疫反応による組織障害改善治療剤
JPH08277224A (ja) 抗炎症剤
CN103536610B (zh) 三七皂苷Fc的医药用途
JPS6289624A (ja) 播種性血管内凝固症候群予防・治療剤
Gryn et al. Factors affecting purification of CD34+ peripheral blood stem cells using the Baxter Isolex 300i
AU737861B2 (en) Remedies for AIDS
CN115282280A (zh) TGF-β1信号抑制剂的新用途
JPS5939403B2 (ja) 抗トロンビン様薬剤
Kuebler et al. Treatment of metastatic renal cell carcinoma with recombinant interleukin-2 in combination with vinblastine or lymphokine-activated killer cells
JP3769045B2 (ja) 抗炎症剤
JPS6272620A (ja) 播種性血管内凝固症候群予防・治療剤
JPS6272613A (ja) 播種性血管内凝固症候群予防・治療剤
CA2380908A1 (en) Plasma substitute composition
Shibayama et al. Role of activated macrophages in augmentation of endotoxin hepatotoxicity
Ordonez et al. Genetic polymorphism of methylenetetrahydrofolate reductase and venous thromboembolism: a case-control study